Huge Plaque Psoriasis Breakthrough at Eli Lilly
Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.
All Work
Chris Lange
Breakthrough Gastrointestinal Tumor Therapy Reaches New Milestone
Deciphera Pharma shares nearly doubled on Tuesday after the firm announced top-line results from its late-stage trial treating patients with gastrointestinal stromal tumors.
Advance Auto Parts Earnings Hit the Brakes
Advance Auto Parts released disappointing second-quarter financial results before the markets opened on Tuesday.
Why Roku Still Has More Upside Than Netflix
Roku shares have absolutely exploded in 2019 and it seems that analysts can’t raise their price targets quick enough.
What to Expect When Tilray Reports on Tuesday
Tilray is scheduled to release its second-quarter financial results after the markets close on Tuesday, and analysts anticipate a net loss.
Short Sellers Make a Move on Big Biotechs
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Major Pharma Sees Rising Tide in Short Interest
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Semiconductor Short Sellers Hike Their Bets
The July 31 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
China Tariff Delay Comes to Market’s Rescue
The S&P 500 and Dow are turning it around after a two-day losing streak. This comes on the heels of news that the United States has removed some items from the list of China…
Alibaba, Cisco, Nvidia, Walmart and More Earnings Coming This Week
24/7 Wall St. has put together a preview of the most prominent earnings reports expected this week, including Cisco, Deere and Walmart.
Is Amarin’s Cardio Trial in Trouble?
Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application.
Activision Blizzard Needs to Level Up After Q2
Activision Blizzard shares retreated after it reported lower quarterly results than a year ago, though the numbers were better than Wall Street expected.
What’s Driving Uber’s Q2 Into the Ground
Uber released second-quarter financial results after markets closed Wednesday. The company said that it had a net loss of $4.72 per share and $3.17 billion in revenue, compared with consensus estimates that called for…
Is This the Turning Point for Stamps.com?
Stamps.com Inc. (NASDAQ: STMP) was absolutely crushed last quarter after it terminated its deal with the U.S. Post Office. While shares might still be down on the year, this quarter very well could be…
Analysts Are Chasing Roku Even Higher
After Wednesday's earnings report, analysts were quick to lift their target prices on Roku, but this raises a couple of questions. Such as, can Roku keep up the pace?
What to Expect When Uber Reports After the Close
Uber is scheduled to release its second-quarter results after the markets close on Thursday. Rival Lyft reported mixed results on Wednesday.
Revolutionary Peanut Allergy Treatment Is One Step Closer
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
Why Kraft Heinz Is Still Not Palatable for Investors
Kraft Heinz released a delayed first half (first and second quarter combined) earnings report before the markets opened on Thursday. This first-quarter report was delayed as the result of an SEC investigation of its…
Is Lyft Finally Getting It Right This Quarter?
Lyft released its second quarter financial results after the markets closed on Wednesday. The company said that it had a net loss of $2.23 per share and $867.26 million in revenue, compared with consensus…
Roku Just Keeps Going After Q2 Results
Roku reported its most recent quarterly results after the markets closed on Wednesday. The firm posted a net loss of $0.08 per share and $250.1 million in revenue, which compares with consensus estimates that…